Clinical Trial Detail

NCT ID NCT02277093
Title Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Washington University School of Medicine
Indications

colorectal cancer

Therapies

Pacritinib

Age Groups: adult

No variant requirements are available.